Although our primary focus was a class I mutant, we observed that a prominent class II mutant exhibits a similar mRNA-level effect (this study) and corresponding protein-level rhodopsin downregulation [96], suggesting that the dominant-negative effect is a shared outcome in RP. The gene discussed is RHO; the disease is retinitis pigmentosa 1.